[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.119.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1995

Premenstrual Dysphoric Disorder and Response to Cholecystokinin-Tetrapeptide

Author Affiliations

St Mary's Hospital McGill University 3830 Lacombe Ave Montreal, Quebec, Canada H3T 1M5
Toronto, Ontario
Montreal

Arch Gen Psychiatry. 1995;52(7):605-606. doi:10.1001/archpsyc.1995.03950190087012
Abstract

We read with interest the article by Leibenluft and colleagues1 in the October 1994 issue of the Archives, which summarized the clinical data on how menstrual cycles can influence biochemical responses to biological challenges. Although the review emphasized mood disorder studies, the authors' conclusions can be extended to biological research in panic disorder. An overlooked area in biological studies of panic disorder is the influence of menstrual cycles and premenstrual syndrome on behavioral sensitivity to panicogenic agents. In this regard, we conducted a study to compare the behavioral response of normal women with and without premenstural dysphoric disorder (PDD) to systemic administration of cholecystokinin-tetrapeptide (CCK-4), a well-validated panicogenic agent. We present herein preliminary data collected from 12 women with PDD and 13 women without PDD.

All of our subjects were screened with the Structured Clinical Interview for DSM-III-R, Non-Patient Editor2 to exclude those with Axis I disorders. The

First Page Preview View Large
First page PDF preview
First page PDF preview
×